rheumatologyadvisor.com
Crohn Disease Exclusion Diet Induces Clinical Remission in Pediatric Patients
This study suggests a Crohn disease exclusion diet (with partial enteral nutrition) helped some pediatric patients reach steroid-free clinical remission and lowered fecal calprotectin, measures important for disease control. Diet-based strategies may offer a nonpharmacologic option to discuss with care teams.
Pediatric patients with Crohn disease and their parents/caregivers, pediatric gastroenterologists, IBD dietitians, and clinicians interested in nonpharmacologic remission strategies.
What To Know
A single-center retrospective chart review presented at Crohn’s & Colitis Congress reports that a Crohn disease exclusion diet (CDED) plus partial enteral nutrition was associated with clinical improvement and reductions in fecal calprotectin in a small group of pediatric patients who adopted the diet.
Of the patients who adhered through 24 weeks, most achieved steroid-free clinical remission; a few had endoscopic assessment with some showing mucosal healing. Reported adverse effects were mild (abdominal pain, diarrhea, weight loss) in some patients. This appears to be real-world, single-center observational data rather than a randomized controlled trial.
The report is based on a subset of patients who received dietitian education and chose to start the diet, and only a small number completed follow-up with biomarkers or endoscopy.
If you’re caring for or are a pediatric patient with Crohn disease, this study suggests CDED may be worth discussing with your gastroenterology team and dietitian as a possible option to induce remission, but it does not establish effectiveness for all patients or replace standard medical therapy.
Read the original conference abstract or speak with your clinician to understand applicability, monitoring (including calprotectin), and potential side effects before making dietary changes.
Findings come from a retrospective, single-center chart review presented as a conference abstract; only a small subset of patients initiated and completed the diet with follow-up. This is not a randomized trial, so results may reflect selection bias and limited sample size. No immediate change to standard care is implied—discuss with clinicians and dietitians.
